In the big picture, matched sibling donor transplants remain the standard of care, Boelens said. But gene therapy is ...

These companies could innovate their way to success.

Wondering whether Vertex Pharmaceuticals is still worth buying at around $452 a share, or if the big gains are already behind ...

Vertex Pharmaceuticals recently reported clinical data showing that CASGEVY helped all evaluable children aged 5–11 with ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Vertex Pharmaceuticals presents clinical data demonstrating benefits of Casgevy in SCD and TDT patients aged 5+ at ASH ...

One of the practical applications of thinking long-term is to buy and hold exceptional stocks with strong growth prospects.

The International Society for Stem Cell Research (ISSCR) today opened its sold-out international symposium, Accelerating ...

Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00. Chen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Vertex ...

Nandkumar M. Kamat As the year is about to end, here is a short review of important breakthroughs in science that defined the ...

CFOs, including Gunnar Wiedenfels of Warner Bros Discovery and Colette Kress of Nvidia, addressed disciplined spending, ...